Side-by-side comparison of AI visibility scores, market position, and capabilities
India's leading digital health platform — doctor discovery, telemedicine, clinic software, and health plans. FY25 revenue ~₹350-400 Cr; 2026 IPO preparation underway; expanding to UAE and US.
Practo is India''s largest digital health platform, providing consumers with doctor discovery, online appointment booking, video consultations, health plans, and diagnostic services. On the B2B side, Practo offers clinic management software used by thousands of healthcare providers across India. Founded in Bengaluru, the company serves a broad population seeking affordable and accessible healthcare, with over 2 lakh (200,000) doctors listed. Practo achieved its first fully profitable quarter in late FY2024 and is on track for sustained profitability, with FY2024–25 revenue estimated at ₹350–400 crore. The company expanded to the UAE in 2025 and launched a U.S. care navigation platform in January 2026, targeting an annualized GMV run-rate of $1B by mid-2026. Practo is preparing for a second-half 2026 IPO in India.
Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.
Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.